Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
38878126
PubMed Central
PMC11729071
DOI
10.1007/s40618-024-02409-z
PII: 10.1007/s40618-024-02409-z
Knihovny.cz E-zdroje
- Klíčová slova
- Hypothyroidism, Levothyroxine, Obesity, Survey,
- MeSH
- dospělí MeSH
- hormony štítné žlázy * krev MeSH
- hypotyreóza epidemiologie terapie farmakoterapie MeSH
- lékařská praxe - způsoby provádění statistika a číselné údaje normy MeSH
- lidé středního věku MeSH
- lidé MeSH
- obezita * epidemiologie terapie MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
- Názvy látek
- hormony štítné žlázy * MeSH
PURPOSE: The use of thyroid hormones (TH) to treat obesity is unsupported by evidence as reflected in international guidelines. We explored views about this practice, and associations with respondent characteristics among European thyroid specialists. METHODS: Specialists from 28 countries were invited to a survey via professional organisations. The relevant question was whether "Thyroid hormones may be indicated in biochemically euthyroid patients with obesity resistant to lifestyle interventions". RESULTS: Of 17,232 invitations 5695 responses were received (33% valid response rate; 65% women; 90% endocrinologists). Of these, 290 (5.1%) stated that TH may be indicated as treatment for obesity in euthyroid patients. This view was commoner among non-endocrinologists (8.7% vs. 4.7%, p < 0.01), private practice (6.5% vs. 4.5%, p < 0.01), and varied geographically (Eastern Europe, 7.3%; Southern Europe, 4.8%; Western Europe, 2.7%; and Northern Europe, 2.5%). Respondents from Northern and Western Europe were less likely to use TH than those from Eastern Europe (p < 0.01). Gross national income (GNI) correlated inversely with this view (OR 0.97, CI: 0.96-0.97; p < 0.001). Having national guidelines on hypothyroidism correlated negatively with treating obesity with TH (OR 0.71, CI: 0.55-0.91). CONCLUSIONS: Despite the lack of evidence, and contrary to guidelines' recommendations, about 5% of respondents stated that TH may be indicated as a treatment for obesity in euthyroid patients resistant to life-style interventions. This opinion was associated with (i) respondent characteristics: being non-endocrinologist, working in private practice, treating a small number of hypothyroid patients annually and (ii) national characteristics: prevalence of obesity, Eastern Europe, low GNI and lack of national hypothyroidism guidelines.
Cabinet Médical 2 Rue Bellefontaine Lausanne Switzerland
Clinic of Endocrinology and Metabolism University Hospital Alexandrovska Sofia Bulgaria
Department of Endocrinology and Diabetes Centre Hellenic Red Cross Hospital Athens Greece
Department of Endocrinology and Metabolism Koru Ankara Hospital Kizilirmak Ankara Turkey
Department of Endocrinology and Metabolism Regina Apostolorum Hospital Rome Italy
Department of Endocrinology Belarusian State Medical University Minsk Republic of Belarus
Department of Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania
Department of Endocrinology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
Department of Endocrinology Odense University Hospital Odense Denmark
Department of Endocrinology Skåne University Hospital Malmö Sweden
Department of Endocrinology Tampere University Hospital Tampere Finland
Department of Internal Medicine and Endocrinology Medical University of Warsaw Warsaw Poland
Department of Internal Medicine Medical University Sofia Sofia Bulgaria
Department of Medicine Universidad Autónoma de Madrid Madrid Spain
Department of Surgery Tampere University Hospital Tampere Finland
Diabetes and Endocrinology Section Beacon Hospital Beacon Court Dublin Ireland
Division of Endocrinology 5 Fazzi Hospital Lecce Italy
Division of Endocrinology Diabetes and Metabolism University of Lausanne Lausanne Switzerland
East Surrey Hospital Surrey and Sussex Healthcare NHS Trust Redhill Surrey UK
Faculty of Medicine University of Belgrade Belgrade Serbia
Institute of Translational and Clinical Research Newcastle University Newcastle Upon Tyne UK
Instituto de Investigación Sanitaria de Navarra Pamplona Spain
Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana Majadahonda Madrid Spain
Robert Graves Institute Tallaght University Hospital Dublin Ireland
School of Medicine University College Dublin Dublin Ireland
Scientific Committee Associazione Medici Endocrinologi Milan Italy
Thyroid and Osteoporosis Praxis Kumberg Austria
Thyroid Practice for Radiofrequency Ablation Vienna Austria
Thyroid Task Force From the Sociedad Española de Endocrinología y Nutrición Madrid Spain
Zobrazit více v PubMed
Negro R, Attanasio R, Nagy EV, Papini E, Perros P, Hegedüs L (2020) Use of thyroid hormones in hypothyroid and euthyroid patients; the 2019 Italian survey. Eur Thyroid J. 9:25–31. 10.1159/000502057 PubMed PMC
Borissova A-MI, Boyanov MA, Attanasio R, et al (2020) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of Bulgarian physicians (Бългapcкo дpyжecтвo пo eндoкpинoлoгия). Endokrinologia (Sofia) 24: 229–309. https://endo-bg.com/en/prilozhenie-na-hormonite-na-shtitovidnata-zhleza-pri-hipotireoidni-i-eutireoidni-patsienti-anketno-prouchvane-thesis-sred-balgarski-lekari/
Niculescu DA, Attanasio R, Hegedüs L, Nagy EV, Negro R, Papini E, Perros P, Poiana C (2020) Use of thyroid hormones in hypothyroid and euthyroid patients: a Thesis* questionnaire survey of Romanian physicians *Thesis: treatment of hypothyroidism in europe by specialists: an international survey. Acta Endocrinol (Buchar). 16:462–469. 10.4183/aeb.2020.462 PubMed PMC
Bednarczuk T, Attanasio R, Hegedüs L, Nagy EV, Negro R, Papini E, Perros P, Ruchała M (2021) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of polish physicians. *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey. Endokrynol Pol 72:357–365. 10.5603/EP.a2021.0048 PubMed
Riis KR, Frølich JS, Hegedüs L, Negro R, Attanasio R, Nagy EV, Papini E, Perros P, Bonnema SJ (2021) (2021) Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Danish endocrine society. J Endocrinol Invest 44:2435–2444. 10.1007/s40618-021-01555-y PubMed PMC
Planck T, Lantz M, Perros P, Papini E, Attanasio R, Nagy EV, Hegedüs L (2021) Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Swedish endocrine society. Front Endocrinol (Lausanne). 6(12):795111. 10.3389/fendo.2021.795111 PubMed PMC
Shepelkevich AP, Dydyshka YV, Yurenya EV, Lobashova VL, Attanasio R, Hegedüs L, Nagy E, Negro R, Papini E, Perros P (2021) Features of the use of synthetic analogues of thyroid hormones: a 2020 THESIS* questionnaire survey of members of the Belarusian public medical association of endocrinology and metabolism. Probl Endokrinol (Mosk). 68:18–26. 10.14341/probl12828. (Russian) PubMed PMC
Metso S, Hakala T, Attanasio R et al (2021) Use of thyroid hormones in the treatment of hypothyroidism: thesis questionnaire survey for Finnish specialists. Finnish Medical Journal 48:2885–9. https://www.laakarilehti.fi/files/pdf/SLL482021-2885-en.pdf
Buffet C, Belin L, Attanasio R, Negro R, Hegedüs L, Nagy EV, Papini E, Perros P, Leenhardt L (2022) Real-life practice of thyroid hormone use in hypothyroid and euthyroid patients: a detailed view from the THESIS questionnaire survey in France. Ann Endocrinol (Paris) 83:27–34. 10.1016/j.ando.2021.11.002 PubMed
Paschou SA, Alevizaki M, Attanasio R, Hegedüs L, Nagy EV, Papini E, Perros P, Vryonidou A (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Hellenic endocrine society. Horm (Athens) 21:103–111. 10.1007/s42000-021-00335-w PubMed
Burlacu MC, Attanasio R, Hegedüs L, Nagy EV, Papini E, Perros P, Sawadogo K, Bex M, Corvilain B, Daumerie C, Decallonne B, Gruson D, Lapauw B, Reyes RM, Petrossians P, Poppe K, Van den Bruel A, Unuane D (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey. Thyroid Res 15:3. 10.1186/s13044-022-00121-9 PubMed PMC
Berta E, Lengyel IM, Hegedűs L, Papini E, Perros P, Negro R, Attanasio R, Nagy VE, Bodor M (2022) Pajzsmirigyhormon-kezelési szokások Magyarországon: A THESIS kérdőíves felmérés eredményei [Use of thyroid hormones in hypothyroid and euthyroid patients: A THESIS questionnaire survey of Hungarian physicians]. Orv Hetil 163:463–472. 10.1556/650.2022.32412. (Hungarian) PubMed
Jiskra J, Paleček J, Attanasio R, Hegedüs L, Nagy EV, Papini E, Perros P, Negro R, Kršek M (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Czech society of endocrinology. BMC Endocr Disord 22:117. 10.1186/s12902-022-01027-1 PubMed PMC
Galofré JC, Attanasio R, Hegedüs L, Nagy E, Negro R, Papini E, Perros P, Díez JJ (2022) Use of thyroid hormone in hypothyroid patients and euthyroid subjects in Spain: a THESIS* questionnaire survey. Endocrinol Diabetes Nutr (Engl Ed). 69:520–529. 10.1016/j.endien.2022.07.001 PubMed
Marques Puga F, Simões H, Melo M, Attanasio R, Hegedüs L, Nagy E, Papini E, Perros P, Freitas C (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS questionnaire survey of Portuguese endocrinologists. Rev Portug Endocrinol Diabetes Metab 17:9–18. 10.26497/ao200050
Vardarli I, Brandenburg T, Hegedüs L, Attanasio R, Nagy E, Papini E, Perros P, Weidemann F, Herrmann K, Führer D (2022) A questionnaire survey of german thyroidologists on the use of thyroid hormones in hypothyroid and euthyroid patients: the THESIS (treatment of hypothyroidism in Europe by specialists: an international survey) collaborative. Exp Clin Endocrinol Diabetes 130:577–586. 10.1055/a-1832-0644 PubMed
Ayvaz G, Akarsu E, Unlu Ersoy R, Sayiner ZA, Attanasio R, Hegedüs L, Nagy EV, Negro R, Papini E, Perros P (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of Turkish physicians. Turk J Endocrinol Metab. 26:85–91. 10.5152/tjem.2022.22024
Beleslin Nedeljkovic B, Attanasio R, Hegedüs L, Nagy E, Negro R, Papini E et al (2022) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* questionnaire survey of Serbian physicians. Serb Arch Med. 150:667–674. 10.2298/SARH211221110N
Younes YR, Perros P, Hegedüs L, Papini E, Nagy EV, Attanasio R, Negro R, Field BCT (2023) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS questionnaire survey of UK endocrinologists. Clin Endocrinol (Oxf) 98:238–248. 10.1111/cen.14812 PubMed PMC
Mustafa M, Ali E, McGowan A, McCabe L, Hegedüs L, Attanasio R, Nagy EV, Papini E, Perros P, Moran C (2023) Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS questionnaire survey of members of the Irish endocrine society. Ir J Med Sci 192:2179–2187. 10.1007/s11845-022-03235-z PubMed PMC
Žarković M, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Cohen CA, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Ćirić J, Díez JJ, Dobnig H, Fadeyev V, Field BCT, Fliers E, Frølich JS, Führer D, Galofré JC, Hakala T, Jiskra J, Kopp P, Krebs M, Kršek M, Kužma M, Lantz M, Lazúrová I, Leenhardt L, Luchytskiy V, McGowan A, Melo M, Metso S, Moran C, Morgunova T, Mykola T, Beleslin BN, Niculescu DA, Perić B, Planck T, Poiana C, Puga FM, Robenshtok E, Rosselet P, Ruchala M, Riis KR, Shepelkevich A, Unuane D, Vardarli I, Visser WE, Vrionidou A, Younes YR, Yurenya E, Hegedüs L (2023) Characteristics of specialists treating hypothyroid patients: the “THESIS” collaborative. Front Endocrinol (Lausanne) 14:1225202. 10.3389/fendo.2023.1225202.PMID:38027187;PMCID:PMC10660282 PubMed PMC
Attanasio R, Žarković M, Papini E, Nagy EV, Negro R, Perros P, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Ćirić J, Díez JJ, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führer-Sakel D, Galofré JC, Hakala T, Jiskra J, Kopp PA, Krebs M, Kršek M, Kužma M, Lantz M, Lazúrová I, Leenhardt L, Luchytskiy V, Marques Puga F, McGowan A, Metso S, Moran C, Morgunova T, Niculescu DA, Perić B, Planck T, Poiana C, Robenshtok E, Rosselet PO, Ruchala M, Ryom Riis K, Shepelkevich A, Tronko MD, Unuane D, Vardarli I, Visser WE, Vryonidou A, Younes YR, Hegedüs L (2023) Patients’ persistent symptoms, clinician demographics, and geo-economic factors are associated with choice of therapy for hypothyroidism by european thyroid specialists: The “THESIS” collaboration. Thyroid 34:429–441. 10.1089/thy.2023.0580. (Epub 2024 Mar 22 PMID: 38368541) PubMed
Kim B (2008) Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18:141–144. 10.1089/thy.2007.0266 PubMed
Pearce EN (2012) Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes 19:408–413. 10.1097/MED.0b013e328355cd6c PubMed
Santos Palacios S, Llavero Valero M, Brugos-Larumbe A, Díez JJ, Guillén-Grima F, Galofré JC (2018) Prevalence of thyroid dysfunction in a large southern European population. Analysis of modulatory factors. The APNA study Clin Endocrinol (Oxf) 89:367–375. 10.1111/cen.13764 PubMed
Díez JJ, Iglesias P (2011) Relationship between thyrotropin and body mass index in euthyroid subjects. Exp Clin Endocrinol Diabetes 119:144–150. 10.1055/s-0030-1265133 PubMed
Biondi B (2010) Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab 95:3614–3617. 10.1210/jc.2010-1245 PubMed
Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, Skarulis MC, Kozlosky M, Csako G, Costello R, Pucino F (2011) Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab 96:3466–3474. 10.1210/jc.2011-1329 PubMed PMC
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH (2013) Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. Eur J Endocrinol 170:341–348. 10.1530/EJE-13-0708 PubMed
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH (2013) Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS ONE 8:e66711. 10.1371/journal.pone.0066711 PubMed PMC
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH (2013) Graves’ disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid 23:408–413. 10.1089/thy.2012.0500 PubMed
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L (2018) Over- and under-treatment of hypothyroidism is associated with excess mortality: a register-based cohort study. Thyroid 28:566–574. 10.1089/thy.2017.0517 PubMed
Hegedüs L, Bianco AC, Jonklaas J, Pearce SH, Weetman AP, Perros P (2022) Primary hypothyroidism and quality of life. Nat Rev Endocrinol 18:230–242. 10.1038/s41574-021-00625-8 PubMed PMC
R Core Team (2021) R: a language and environment for statistical computing . Vienna, Austria: R foundation for statistical computing. https://www.R-project.org/
Agresti A (2019) An introduction to categorical data analysis, 3rd edn. John Wiley & Sons, Hoboken
Rea LM, Parker RA (2014) Designing and conducting survey research: a comprehensive guide, 4th edn. Jossey-Bass, a Wiley brand, San Francisco
Sullivan GM, Feinn R (2012) Using effect size-or why the P value is not enough. J Grad Med Educ 4:279–282. 10.4300/JGME-D-12-00156.1 PubMed PMC
United Nations Statistics Division. UNSD. https://unstats.un.org/unsd/methodology/m49/ Accessed 19 Mar 2023
The World Bank. GNI per capita ranking, atlas method and PPP based data catalog. https://datacatalog.worldbank.org/search/dataset/0038128. Accessed 19 Mar 2023
https://data.worldbank.org/. Accessed 19 Mar 2023
https://apps.who.int/gho/data/node.main.A904?lang=en. Accessed 19 Mar 2023
Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM (2020) European society of endocrinology clinical practice guideline: endocrine work-up in obesity. Eur J Endocrinol 182:G1–G32. 10.1530/EJE-19-0893 PubMed
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L (2019) Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol 180:407–416. 10.1530/EJE-19-0006 PubMed
Markwick A, Vaughan L, Ansari Z (2013) Opposing socioeconomic gradients in overweight and obese adults. Aust N Z J Public Health 37:32–38. 10.1111/1753-6405.12007 PubMed
Zhou M (2021) The shifting income-obesity relationship: conditioning effects from economic development and globalization. SSM Popul Health. 15:100849. 10.1016/j.ssmph.2021.100849 PubMed PMC
Díez JJ, Iglesias P (2023) Prevalence of thyroid dysfunction and its relationship to income level and employment status: a nationwide population-based study in Spain. Horm (Athens) 22:243–252. 10.1007/s42000-023-00435-9 PubMed
Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L (2013) Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. A nationwide register study. PLoS ONE 8:e75789. 10.1371/journal.pone.0075789 PubMed PMC
Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedüs L (2014) Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study. Thyroid 24:802–808. 10.1089/thy.2013.0555 PubMed
Thvilum M, Brandt F, Brix TH, Hegedüs L (2014) Hypothyroidism is a predictor of disability pension and loss of labor market income: a Danish register-based study. J Clin Endocrinol Metab 99:3129–3135. 10.1210/jc.2014-1407 PubMed
Fox CS, Pencina MJ, D’Agostino RB, Murabito JM, Seely EW, Pearce EN, Vasan RS (2008) Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 168:587–592. 10.1001/archinte.168.6.587 PubMed
Valdés S, Maldonado-Araque C, Lago-Sampedro A, Lillo-Muñoz JA, Garcia-Fuentes E, Perez-Valero V, Gutiérrez-Repiso C, Garcia-Escobar E, Goday A, Urrutia I, Peláez L, Calle-Pascual A, Bordiú E, Castaño L, Castell C, Delgado E, Menéndez E, Franch-Nadal J, Gaztambide S, Girbés J, Ortega E, Vendrell J, Chacón MR, Javier Chaves F, Soriguer F, Rojo-Martínez G (2017) Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study. Obes (Silver Spring) 25:788–793. 10.1002/oby.21796
Janssen IM, Homan J, Schijns W, Betzel B, Aarts EO, Berends FJ, de Boer H (2015) Subclinical hypothyroidism and its relation to obesity in patients before and after Roux-en-Y gastric bypass. Surg Obes Relat Dis 11:1257–1263. 10.1016/j.soard.2015.02.021 PubMed
Basolo A, Poma AM, Giannini R, Ceccarini G, Pelosini C, Fierabracci P, Castany MU, Bechi Genzano S, Ambrosini CE, Materazzi G, Chiovato L, Basolo F, Santini F, Torregrossa L (2022) Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity. J Endocrinol Invest 45:413–423. 10.1007/s40618-021-01662-w. (Epub 2021 Aug 15 PMID: 34392500) PubMed
Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA (2006) Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol (Oxf) 64:125–128. 10.1111/j.1365-2265.2006.02433.x. (PMID: 16430708) PubMed
Urrea CR, Pedroso AP, Thomazini F, do Carmo ACF, Telles MM, Sawaya AL, Franco MDCP, Ribeiro EB. (2023) Thyroid axis hormones and anthropometric recovery of children/adolescents with overweight/obesity: a scoping review. Front Nutr 9:1040167. 10.3389/fnut.2022.1040167 PubMed PMC
Abrahamsen B, Jørgensen HL, Laulund AS, Nybo M, Bauer DC, Brix TH, Hegedüs L (2015) The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis. J Bone Miner Res 30:898–905. 10.1002/jbmr.2416 PubMed
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L (2019) Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk. Thyroid 29:332–340. 10.1089/thy.2018.0320 PubMed
Gómez-Pérez AM, Fernández-García JC, Iglesias P, Díez JJ, Álvarez-Escolá C, Lecumberri B, Lucas-Martín A, Donnay S, Cabrejas-Gómez C, Menéndez-Torre E, Galofré JC, en representación del Área de Conocimiento de Tiroides de la SEEN (2020) Diagnosis and treatment of thyroid nodules in Spain. Results of a national survey. Endocrinol Diabetes Nutr (Engl Ed). 67:438–445. 10.1016/j.endinu.2019.10.003 PubMed
Cassemiro JF, Ilera V, Batalles S, Reyes A, Nagy EV, Papini E, Perros P, Hegedüs L, Ramos HE (2023) Use of thyroid hormones in hypothyroid and euthyroid patients: a 2022 THESIS questionnaire survey of members of the Latin American Thyroid Society (LATS). Thyroid Res 16:40. 10.1186/s13044-023-00182-4 PubMed PMC
Lafontaine N, Brown SJ, Perros P, Papini E, Nagy EV, Attanasio R, Hegedüs L, Walsh JP (2024) Use of thyroid hormones in hypothyroid and euthyroid patients: a survey of members of the endocrine society of Australia. Clin Endocrinol (Oxf) 100:477–485. 10.1111/cen.15049 PubMed
Díez JJ, Iglesias P (2023) Control of thyroid dysfunction in Spanish population registered in primary care clinical database: an analysis of the proportion of patients with thyrotropin values outside the reference range. Horm Metab Res 55:184–190. 10.1055/a-2014-458 PubMed